Impact Biomedicines - Ownership and Business Overview

Life ScienceCompany

Impact Biomedicines Ownership

Who owns Impact Biomedicines?

Impact Biomedicines is owned by Celgene. It was acquired on January 7, 2018.

Impact Biomedicines Business Overview

Where is Impact Biomedicines headquartered?

Impact Biomedicines is headquartered in San Diego, California.

What sector is Impact Biomedicines in?

Impact Biomedicines is a life science company.

When was Impact Biomedicines founded?

Impact Biomedicines was founded in 2016.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.

Impact Biomedicines, Inc.

12526 High Bluff Drive, Suite 260,
San Diego, California 92130
United States,
(858) 221-0950
www.impactbiomedicines.com

Impact Biomedicines, Inc. is a developer of life changing treatments for patients with complex cancers. Impact Biomedicines was founded in 2016 and is based in San Diego, United States.


 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.